Mass Histology to Quantify Neurodegeneration in Drosophila
- PMID: 28060320
- PMCID: PMC5226413
- DOI: 10.3791/54809
Mass Histology to Quantify Neurodegeneration in Drosophila
Abstract
Progressive neurodegenerative diseases like Alzheimer's disease (AD) or Parkinson's disease (PD) are an increasing threat to human health worldwide. Although mammalian models have provided important insights into the underlying mechanisms of pathogenicity, the complexity of mammalian systems together with their high costs are limiting their use. Therefore, the simple but well-established Drosophila model-system provides an alternative for investigating the molecular pathways that are affected in these diseases. Besides behavioral deficits, neurodegenerative diseases are characterized by histological phenotypes such as neuronal death and axonopathy. To quantify neuronal degeneration and to determine how it is affected by genetic and environmental factors, we use a histological approach that is based on measuring the vacuoles in adult fly brains. To minimize the effects of systematic error and to directly compare sections from control and experimental flies in one preparation, we use the 'collar' method for paraffin sections. Neurodegeneration is then assessed by measuring the size and/or number of vacuoles that have developed in the fly brain. This can either be done by focusing on a specific region of interest or by analyzing the entire brain by obtaining serial sections that span the complete head. Therefore, this method allows one to measure not only severe degeneration but also relatively mild phenotypes that are only detectable in a few sections, as occurs during normal aging.
Similar articles
-
Uncoupling neuronal death and dysfunction in Drosophila models of neurodegenerative disease.Acta Neuropathol Commun. 2016 Jun 23;4(1):62. doi: 10.1186/s40478-016-0333-4. Acta Neuropathol Commun. 2016. PMID: 27338814 Free PMC article.
-
Knockdown of APPL mimics transgenic Aβ induced neurodegenerative phenotypes in Drosophila.Neurosci Lett. 2017 May 1;648:8-13. doi: 10.1016/j.neulet.2017.03.030. Epub 2017 Mar 20. Neurosci Lett. 2017. PMID: 28336338
-
Analysis of dopaminergic neuronal dysfunction in genetic and toxin-induced models of Parkinson's disease in Drosophila.J Neurochem. 2014 Nov;131(3):369-82. doi: 10.1111/jnc.12818. Epub 2014 Jul 31. J Neurochem. 2014. PMID: 25040725
-
Drosophila models of neurodegenerative disease.NeuroRx. 2005 Jul;2(3):438-46. doi: 10.1602/neurorx.2.3.438. NeuroRx. 2005. PMID: 16389307 Free PMC article. Review.
-
Chaperoning brain degeneration.Proc Natl Acad Sci U S A. 2002 Dec 10;99 Suppl 4(Suppl 4):16407-11. doi: 10.1073/pnas.152330499. Epub 2002 Jul 29. Proc Natl Acad Sci U S A. 2002. PMID: 12149445 Free PMC article. Review.
Cited by
-
Studies of neurodegenerative diseases using Drosophila and the development of novel approaches for their analysis.Fly (Austin). 2022 Dec;16(1):275-298. doi: 10.1080/19336934.2022.2087484. Fly (Austin). 2022. PMID: 35765969 Free PMC article. Review.
-
Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.Glia. 2019 Oct;67(10):1933-1957. doi: 10.1002/glia.23671. Epub 2019 Jul 3. Glia. 2019. PMID: 31267577 Free PMC article.
-
Micro-computed tomography as a platform for exploring Drosophila development.Development. 2019 Dec 11;146(23):dev176685. doi: 10.1242/dev.176685. Development. 2019. PMID: 31722883 Free PMC article.
-
A protocol to detect neurodegeneration in Drosophila melanogaster whole-brain mounts using advanced microscopy.STAR Protoc. 2021 Jul 28;2(3):100689. doi: 10.1016/j.xpro.2021.100689. eCollection 2021 Sep 17. STAR Protoc. 2021. PMID: 34382016 Free PMC article.
-
Heterochromatic silencing of immune-related genes in glia is required for BBB integrity and normal lifespan in drosophila.Aging Cell. 2023 Oct;22(10):e13947. doi: 10.1111/acel.13947. Epub 2023 Aug 18. Aging Cell. 2023. PMID: 37594178 Free PMC article.
References
-
- Bonini NM, Fortini ME. Human neurodegenerative disease modeling using Drosophila. Annu Rev Neurosci. 2003;26:627–656. - PubMed
-
- Calahorro F, Ruiz-Rubio M. Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder. Invert Neurosci. 2011;11:73–83. - PubMed
-
- Gama Sosa MA, De Gasperi R, Elder GA. Modeling human neurodegenerative diseases in transgenic systems. Hum Genet. 2012;131:535–563. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases